Suppr超能文献

通过代谢工程改造的大肠杆菌对两种幽门螺杆菌α-1,3-岩藻糖基转移酶直系同源基因进行评估,用于大规模合成LewisX人乳寡糖。

Assessment of the two Helicobacter pylori alpha-1,3-fucosyltransferase ortholog genes for the large-scale synthesis of LewisX human milk oligosaccharides by metabolically engineered Escherichia coli.

作者信息

Dumon Claire, Samain Eric, Priem Bernard

机构信息

CERMAV-CNRS, 601 Rue de la Chimie, BP 53, 38041 Grenoble Cedex 09, France.

出版信息

Biotechnol Prog. 2004 Mar-Apr;20(2):412-9. doi: 10.1021/bp0342194.

Abstract

We previously described a bacterial fermentation process for the in vivo conversion of lactose into fucosylated derivatives of lacto-N-neotetraose Gal(beta1-4)GlcNAc(beta1-3)Gal(beta1-4)Glc (LNnT). The major product obtained was lacto-N-neofucopentaose-V Gal(beta1-4)GlcNAc(beta1-3)Gal(beta1-4)[Fuc(alpha1-3)]Glc, carrying fucose on the glucosyl residue of LNnT. Only a small amount of oligosaccharides fucosylated on N-acetylglucosaminyl residues and thus carrying the LewisX group (Le(X)) was also produced. We report here a fermentation process for the large-scale production of Le(X) oligosaccharides. The two fucosyltransferase genes futA and futB of Helicobacter pylori (strain 26695) were compared in order to optimize fucosylation in vivo. futA was found to provide the best activity on the LNnT acceptor, whereas futB expressed a better Le(X) activity in vitro. Both genes were expressed to produce oligosaccharides in engineered Escherichia coli (E. coli) cells. The fucosylation pattern of the recombinant oligosaccharides was closely correlated with the specificity observed in vitro, FutB favoring the formation of Le(X) carrying oligosaccharides. Lacto-N-neodifucohexaose-II Gal(beta1-4)[Fuc(alpha1-3)]GlcNAc(beta1-3)Gal(beta1-4)[Fuc(alpha1-3)]Glc represented 70% of the total oligosaccharide amount of futA-on-driven fermentation and was produced at a concentration of 1.7 g/L. Fermentation driven by futB led to equal amounts of both lacto-N-neofucopentaose-V and lacto-N-neofucopentaose-II Gal(beta1-4)[Fuc(alpha1-3)]GlcNAc(beta1-3)Gal(beta1-4)Glc, produced at 280 and 260 mg/L, respectively. Unexpectedly, a noticeable proportion (0.5 g/L) of the human milk oligosaccharide 3-fucosyllactose Gal(beta1-4)[Fuc(alpha1-3)]Glc was produced in futA-on-driven fermentation, underlining the activity of fucosyltransferase FutA in E. coli and leading to a reassessment of its activity on lactose. All oligosaccharides produced by the products of both fut genes were natural compounds of human milk.

摘要

我们之前描述了一种细菌发酵过程,可将乳糖在体内转化为乳糖-N-新四糖Gal(β1-4)GlcNAc(β1-3)Gal(β1-4)Glc(LNnT)的岩藻糖基化衍生物。获得的主要产物是乳糖-N-新岩藻五糖-V Gal(β1-4)GlcNAc(β1-3)Gal(β1-4)[Fuc(α1-3)]Glc,在LNnT的葡萄糖基残基上带有岩藻糖。还仅产生了少量在N-乙酰葡糖胺残基上岩藻糖基化并因此带有LewisX基团(Le(X))的寡糖。我们在此报告一种用于大规模生产Le(X)寡糖的发酵过程。比较了幽门螺杆菌(菌株26695)的两个岩藻糖基转移酶基因futA和futB,以优化体内的岩藻糖基化。发现futA对LNnT受体具有最佳活性,而futB在体外表现出更好的Le(X)活性。两个基因都在工程化大肠杆菌(E. coli)细胞中表达以产生寡糖。重组寡糖的岩藻糖基化模式与体外观察到的特异性密切相关,FutB有利于形成带有Le(X)的寡糖。乳糖-N-新二岩藻六糖-II Gal(β1-4)[Fuc(α1-3)]GlcNAc(β1-3)Gal(β1-4)[Fuc(α1-3)]Glc占futA驱动发酵产生的总寡糖量的70%,其产生浓度为1.7 g/L。由futB驱动的发酵产生等量的乳糖-N-新岩藻五糖-V和乳糖-N-新岩藻五糖-II Gal(β1-4)[Fuc(α1-3)]GlcNAc(β1-3)Gal(β1-4)Glc,分别以280和260 mg/L的浓度产生。出乎意料的是,在futA驱动的发酵中产生了相当比例(0.5 g/L)的人乳寡糖3-岩藻糖基乳糖Gal(β1-4)[Fuc(α1-3)]Glc,这突出了大肠杆菌中岩藻糖基转移酶FutA的活性,并导致对其对乳糖活性的重新评估。由两个fut基因的产物产生的所有寡糖都是人乳中的天然化合物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验